United States · Research startup
Pathogenetix develops biological sensors for the identification of pathogens and biomarkers in air, human serum, and other biological materials.
Funding reportedLast round: Series C
Follow Pathogenetix, Inc. and see its new rounds in your feed.Start following
Funding, as reported
From the SEC filings it signed: 1 on the team.
On the board, as filediFrederick BlumeGus LawlorSteve GullansTara Butler
What they build
Known for
biotechnology researchbiotechnologyb2blife sciences
Built with from their website
Amazon AWS
Add your raise, your deck and your story, and put Pathogenetix, Inc. in front of investors. Or tell us what we have wrong.